Lancome Paris Renergie Lift Volumetry Volumetric Lifting and Reshaping SPF 15 Normal Combination Skin

Dosage form: cream
Ingredients: Avobenzone 1.5g in 50g, Octisalate 2.5g in 50g, Octocrylene 3.5g in 50g
Labeler: L'Oreal USA Products Inc
NDC Code: 49967-857

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Facts

Active ingredients

Active Ingredients: Avobenzone 3%, Octisalate 5%, Octocrylene 7%

Directions

Directions

Apply before sun exposure.

Warnings

WARNINGS: FOR EXTERNAL USE ONLY, NOT TO BE SWALLOWED. AVOID CONTACT WITH EYES. IF CONTACT OCCURS, RINSE EYES THOROUGHLY WITH WATER. DISCONTINUE USE IF SIGNS OR IRRITATION OR RASH APPEAR. IF IRRITATION OR RASH PERSISTS, CONSULT A DOCTOR. KEEP OUT OF REACH OF CHILDREN.

LANCOME PARIS RENERGIE LIFT VOLUMETRY  VOLUMETRIC LIFTING AND RESHAPING SPF 15 NORMAL COMBINATION SKIN
avobenzone octisalate octocrylene cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49967-857
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Avobenzone (Avobenzone) Avobenzone1.5 g  in 50 g
Octisalate (Octisalate) Octisalate2.5 g  in 50 g
Octocrylene (Octocrylene) Octocrylene3.5 g  in 50 g
Packaging
#Item CodePackage Description
1NDC:49967-857-011 JAR (JAR) in 1 CARTON
150 g in 1 JAR
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart35206/01/2010
Labeler - L'Oreal USA Products Inc (002136794)
Establishment
NameAddressID/FEIOperations
L'Oreal USA Products Inc185931458manufacture

Revised: 06/2010
 
L'Oreal USA Products Inc

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web5)